Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells

Wang,Ying; Chen,Yongchang; Wu,Min; Lan,Ting; Wu,Yan; Li,Yueying; Qian,Hai

doi:10.3892/ol.2015.3173

Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells

Authors:
- Ying Wang
- Yongchang Chen
- Min Wu
- Ting Lan
- Yan Wu
- Yueying Li
- Hai Qian
View Affiliations

Affiliations: Department of Physiology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China
Published online on: May 4, 2015 https://doi.org/10.3892/ol.2015.3173
Pages: 502-508

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Enhanced motility of cancer cells is a critical step in promoting tumor metastasis, which remains the major cause of gastric cancer‑associated mortality. The small GTPase Rac1 is a key signaling component in the regulation of cell migration. Previous studies have demonstrated that Rac1 activity may be regulated by protein kinase G (PKG); however, the underlying mechanism is not yet clear. The current study aimed to investigate the effect of type II cyclic guanosine monophosphate (cGMP)‑dependent protein kinase (PKG II) on Rac1 activity. The human gastric cancer cell line AGS was infected with adenoviral constructs encoding PKG II to increase the expression of this enzyme, and treated with a cGMP analog (8‑pCPT‑cGMP) to induce its activation. A Transwell assay was employed to measure cell migration, and the activity of Rac1 was assessed using a pull‑down assay. Immunoprecipitation was used to isolate the Rac1 protein. Phosphorylation of phosphatidylinositol 4,5 bisphosphate 3 kinase (PI3K) and its downstream effecter protein kinase B (Akt) are associated with lysophosphatidic acid (LPA)‑induced motility/migration of cancer cells. Extracellular signal regulated kinase (ERK) is the major signaling molecule of the Mitogen activated protein kinase (MAPK) mediated signaling pathway. ERK and its upstream activator MAPK kinase (MEK) are also involved in LPA‑induced motility/migration of cancer cells. Phosphorylation of PI3K/Akt, MEK/ERK and enriched Rac1 were detected by western blotting. The results revealed that blocking the activation of Rac1 by ectopically expressing an inactive Rac1 mutant (T17N) impeded LPA‑induced cell migration. Increased PKG II activity inhibited LPA‑induced migration and LPA‑induced activation of Rac1; however, it had no effect on the phosphorylation of Rac1. PKG II also inhibited the activation of PI3K/Akt and MEK/ERK mediated signaling, which is important for LPA‑induced Rac1 activation. These results suggest that PKG II affects LPA‑stimulated migration of AGS cells by blocking Rac1 activation, via inhibition of PI3K/Akt and MEK/ERK mediated signaling.

View Figures

View References

1	Ferlay J, Soerjomataram II, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo MM, Parkin DM, Forman D and Bray F: GLOBOCAN 2012 version 1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer. [online]. 2013, https://gco.iarc.frAccessed. January 20–2014
2	Pfeifer A, Aszódi A, Seidler U, Ruth P, Hofmann F and Fässler R: Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science. 274:2082–2086. 1996. View Article : Google Scholar : PubMed/NCBI
3	Miyazawa T, Ogawa Y, Chusho H, Yasoda A, Tamura N, Komatsu Y, Pfeifer A, Hofmann F and Nakao K: Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology. 143:3604–3610. 2002. View Article : Google Scholar : PubMed/NCBI
4	Tischkau SA, Mitchell JW, Pace LA, Barnes JW, Barnes JA and Gillette MU: Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock. Neuron. 43:539–549. 2004. View Article : Google Scholar : PubMed/NCBI
5	Swartling FJ, Ferletta M, Kastemar M, Weiss WA and Westermark B: Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene. 28:3121–3131. 2009. View Article : Google Scholar : PubMed/NCBI
6	Fallahian F, Karami-Tehrani F, Salami S and Aghaei M: Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines. FEBS J. 278:3360–3369. 2011. View Article : Google Scholar : PubMed/NCBI
7	Chen YC, Ren F, Sang JR, Tao Y and Xu WR: Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823. Mol Med Rep. 3:361–366. 2010.PubMed/NCBI
8	Jiang L, Lan T, Chen Y, Sang J, Li Y, Wu M, Tao Y, Wang Y, Qian H and Gu L: PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells. PLoS One. 8:e616742013. View Article : Google Scholar : PubMed/NCBI
9	Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
10	Tapon N and Hall A: Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 9:86–92. 1997. View Article : Google Scholar : PubMed/NCBI
11	Ellerbroek SM, Wennerberg K and Burridge K: Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem. 278:19023–19031. 2003. View Article : Google Scholar : PubMed/NCBI
12	Schwarz J, Proff J, Hävemeier A, Ladwein M, Rottner K, Barlag B, Pich A, Tatge H, Just I and Gerhard R: Serine-71 phosphorylation of Rac1 modulates downstream signaling. PLoS One. 7:e443582012. View Article : Google Scholar : PubMed/NCBI
13	Wang Y, Chen Y, Li Y, Lan T and Qian H: Type II cGMP-dependent protein kinase inhibits RhoA activation in gastric cancer cells. Mol Med Rep. 9:1444–1452. 2014.PubMed/NCBI
14	Schoentaube J, Olling A, Tatge H, Just I and Gerhard R: Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A. Cell Microbiol. 11:1816–1826. 2009. View Article : Google Scholar : PubMed/NCBI
15	Jones NP and Katan M: Role of phospholipase Cgamma1 in cell spreading requires association with a beta-Pix/GIT1-containing complex, leading to activation of Cdc42 and Rac1. Mol Cell Biol. 27:5790–5805. 2007. View Article : Google Scholar : PubMed/NCBI
16	Du J, Xu R, Hu Z, Tian Y, Zhu Y, Gu L and Zhou L: PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells. PLoS One. 6:e252132011. View Article : Google Scholar : PubMed/NCBI
17	Ray RM, Vaidya RJ and Johnson LR: MEK/ERK regulates adherens junctions and migration through Rac1. Cell Motil Cytoskeleton. 64:143–156. 2007. View Article : Google Scholar : PubMed/NCBI
18	Hu Z, Du J, Yang L, Zhu Y, Yang Y, Zheng D, Someya A, Gu L and Lu X: GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells. PLoS One. 7:e387772012. View Article : Google Scholar : PubMed/NCBI
19	Schoofs G, Monica TJ, Ayala J, Horwitz J, Montgomery T, Roth G and Castillo FJ: A high yielding serum-free, suspension cell process to manufacture recombinant adenoviral vectors for gene therapy. Cytotechnology. 28:81–89. 1998. View Article : Google Scholar : PubMed/NCBI
20	Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett. 582:2093–2101. 2008. View Article : Google Scholar : PubMed/NCBI
21	Ridley AJ: Rho proteins and cancer. Breast Cancer Res Treat. 84:13–19. 2004. View Article : Google Scholar : PubMed/NCBI
22	Soon LL, Yie TA, Shvarts A, Levine AJ, Su F and Tchou-Wong KM: Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem. 278:11465–11470. 2003. View Article : Google Scholar : PubMed/NCBI
23	Langer DA, Das A, Semela D, Kang-Decker N, Hendrickson H, Bronk SF, Katusic ZS, Gores GJ and Shah VH: Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology. 47:1983–1993. 2008. View Article : Google Scholar : PubMed/NCBI
24	Muzaffar S, Shukla N, Bond M, Sala-Newby G, Angelini GD, Newby AC and Jeremy JY: Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619. Prostaglandins Leukot Essent Fatty Acids. 78:247–255. 2008. View Article : Google Scholar : PubMed/NCBI
25	Routray C, Liu C, Yaqoob U, Billadeau DD, Bloch KD, Kaibuchi K, Shah VH and Kang N: Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes. Am J Physiol Cell Physiol. 301:C66–C74. 2011. View Article : Google Scholar : PubMed/NCBI
26	Rolli-Derkinderen M, Toumaniantz G, Pacaud P and Loirand G: RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration. Mol Cell Biol. 30:4786–4796. 2010. View Article : Google Scholar : PubMed/NCBI
27	Hou Y, Ye RD and Browning DD: Activation of the small GTPase Rac1 by cGMP-dependent protein kinase. Cell Signal. 16:1061–1069. 2004. View Article : Google Scholar : PubMed/NCBI
28	Forget MA, Desrosiers RR, Gingras D and Béliveau R: Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J. 361:243–254. 2002. View Article : Google Scholar : PubMed/NCBI
29	Tong J, Li L, Ballermann B and Wang Z: Phosphorylation of Rac1 T108 by extracellular signal-regulated kinase in response to epidermal growth factor: a novel mechanism to regulate Rac1 function. Mol Cell Biol. 33:4538–4551. 2013. View Article : Google Scholar : PubMed/NCBI
30	Kwon T, Kwon DY, Chun J, Kim JH and Kang SS: Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J Biol Chem. 275:423–428. 2000. View Article : Google Scholar : PubMed/NCBI
31	Bian D, Su S, Mahanivong C, Cheng RK, Han Q, Pan ZK, Sun P and Huang S: Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway. Cancer Res. 64:4209–4217. 2004. View Article : Google Scholar : PubMed/NCBI
32	Kim EK, Yun SJ, Do KH, Kim MS, Cho M, Suh DS, Kim CD, Kim JH, Birnbaum MJ and Bae SS: Lysophosphatidic acid induces cell migration through the selective activation of Akt1. Exp Mol Med. 40:445–452. 2008. View Article : Google Scholar : PubMed/NCBI
33	Jans R, Mottram L, Johnson DL, Brown AM, Sikkink S, Ross K and Reynolds NJ: Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation. J Invest Dermatol. 133:793–802. 2013. View Article : Google Scholar : PubMed/NCBI